Advertisement

Malignant Soft Tissue Myxofibrosarcoma

  • Rajesh GuptaEmail author
Chapter

Abstract

Myxofibrosarcoma is an aggressive soft tissue neoplasm that is classified as a type of malignant fibrohistiocytic tumor. The combination of PET and MR imaging is helpful in determining the extent of local infiltration, defining surgical margins, and detection of small satellite lesions. PET/MRI is also useful in monitoring patients’ response to local and systemic therapy.

Keywords

Myxofibrosarcoma Soft tissue sarcoma Fibrohistiocytic tumor FDG PET/MR 

Suggested Reading

  1. Ioannidis JP, Lau J. 18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: a meta-analysis. J Nucl Med. 2003;44:717–24.PubMedGoogle Scholar
  2. Kaya M, Wada T, Nagoya S, Sasaki M, Matsumura T, Yamaguchi T, et al. MRI and histological evaluation of the infiltrative growth pattern of myxofibrosarcoma. Skelet Radiol. 2008;37:1085–90.CrossRefGoogle Scholar
  3. Kikuta K, Kubota D, Yoshida A, Morioka H, Toyama Y, Chuuman H, et al. An analysis of factors related to the tail-like pattern of myxofibrosarcoma seen on MRI. Skelet Radiol. 2015;44:55–62.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of RadiologyStony Brook University HospitalStony BrookUSA

Personalised recommendations